Stockscreener 앱 받기
5.155
4.58%
0.135
전일 마감가:
$5.02
열려 있는:
$5.05
하루 거래량:
101.08K
Relative Volume:
0.21
시가총액:
$8.17M
수익:
-
순이익/손실:
$-14.58M
주가수익비율:
-4.4826
EPS:
-1.15
순현금흐름:
$-9.80M
1주 성능:
-20.45%
1개월 성능:
+15.38%
6개월 성능:
-36.39%
1년 성능:
-85.89%
1일 변동 폭
$4.90
$5.59
1주일 범위
$4.90
$6.7099
52주 변동 폭
$3.80
$38.00
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
명칭
Acurx Pharmaceuticals Inc
전화
917-533-1469
주소
259 LIBERTY AVENUE, STATEN ISLAND
ACXP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
5.155 | 10.45M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.74 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.28 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.20 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.82 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.06 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Acurx Pharmaceuticals Inc 주식(ACXP)의 최신 뉴스
Is Acurx Pharmaceuticals Inc. stock recession proof2025 Short Interest & Stock Market Timing Techniques - newser.com
How to interpret RSI for Acurx Pharmaceuticals Inc. stockMarket Trend Report & Long-Term Capital Growth Ideas - newser.com
Will Acurx Pharmaceuticals Inc. stock split attract more investorsTrade Volume Summary & Safe Capital Investment Plans - newser.com
What is the fair value of Acurx Pharmaceuticals Inc. stock nowMarket Trend Report & Risk Adjusted Buy/Sell Alerts - newser.com
Can Acurx Pharmaceuticals Inc. stock sustain free cash flow growth2025 Breakouts & Breakdowns & Low Risk Investment Opportunities - newser.com
How resilient is Acurx Pharmaceuticals Inc. stock in market downturnsWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - newser.com
What risks investors should watch in Acurx Pharmaceuticals Inc. stockJuly 2025 Highlights & Daily Stock Trend Watchlist - newser.com
Can Acurx Pharmaceuticals Inc. stock attract ESG capital inflowsMarket Performance Report & Weekly Sector Rotation Insights - newser.com
Will Acurx Pharmaceuticals Inc. (3ZO) stock draw ESG focused fundsMarket Movement Recap & Free Low Drawdown Momentum Trade Ideas - newser.com
Can Acurx Pharmaceuticals Inc. stock sustain market leadershipEntry Point & High Conviction Buy Zone Picks - newser.com
Is Acurx Pharmaceuticals Inc. (3ZO) stock overpriced at current multiplesJuly 2025 Spike Watch & Growth Focused Investment Plans - newser.com
How strong is Acurx Pharmaceuticals Inc. (3ZO) stock earnings growthWeekly Trend Report & Fast Gain Stock Tips - newser.com
Pattern recognition hints at Acurx Pharmaceuticals Inc. upsideGold Moves & Free Safe Capital Growth Stock Tips - newser.com
Why Acurx Pharmaceuticals Inc. stock appeals to analystsWeekly Investment Recap & Smart Investment Allocation Tips - newser.com
Will Acurx Pharmaceuticals Inc. stock outperform growth indexesMarket Trend Summary & Daily Oversold Stock Bounce Ideas - newser.com
What dividend safety score for Acurx Pharmaceuticals Inc. stockWeekly Stock Summary & Technical Buy Zone Confirmations - newser.com
Combining price and volume data for Acurx Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Trade Opportunity Analysis Reports - newser.com
Short Interest in Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Grows By 82.1% - Defense World
How supply shortages influence Acurx Pharmaceuticals Inc. (3ZO) stock2025 Key Lessons & Risk Controlled Stock Alerts - newser.com
Multi factor analysis applied to Acurx Pharmaceuticals Inc.Recession Risk & Accurate Buy Signal Notifications - newser.com
Can swing trading help recover from Acurx Pharmaceuticals Inc. lossesPortfolio Update Summary & Consistent Profit Trading Strategies - newser.com
Biodefense Market to Attain USD 32.87 Billion by 2034, Driven by Biotech Advancements and Government Funding - GlobeNewswire Inc.
Can Acurx Pharmaceuticals Inc. (3ZO) stock test all time highsBuy Signal & Fast Exit/Entry Strategy Plans - newser.com
Comparing Acurx Pharmaceuticals Inc. in custom built stock radarsDip Buying & Advanced Swing Trade Entry Alerts - newser.com
Acurx Pharmaceuticals’ Ibezapolstat: Promising Preclinical and Clinical Efficacy Supports Buy Rating - TipRanks
Acurx Pharmaceuticals Shareholders Approve Key Issuance Plans - MSN
Acurx Pharmaceuticals Inc (ACXP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
1.65%
자본화:
|
볼륨(24시간):